REVVITY, INC Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount
REVVITY, INC (RVTY) had Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount of $31.30 million as of 2025-12-28, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Debt and Equity Securities › Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount · last filed 2026-02-24
- 2025-12-28: Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount $31.30M.
- 2024-12-29: Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount $31.30M.
- 2023-12-31: Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount $31.30M.
- 2023-01-01: Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount $30.70M.
| Period end | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount |
|---|---|
| 2025-12-28 | $31.30M 10-K · filed 2026-02-24 |
| 2024-12-29 | $31.30M 10-K · filed 2026-02-24 |
| 2023-12-31 | $31.30M 10-K · filed 2025-02-25 |
| 2023-01-01 | $30.70M 10-K · filed 2024-02-27 |
| 2022-01-02 | $27.80M 10-K · filed 2023-03-01 |
| 2021-01-03 | $8.20M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |